GameStop: Consensus Estimates Point To Negative EBITDA For Q3

GameStop (NYSE: GME) will be reporting its third quarter financial results on December 8th after the market closes. Analysts have a consensus $88 12-month price target on the company, via a total of 3 analysts, with 1 analyst having a hold rating, another analyst having a sell rating, and the last analyst having a strong sell rating. The street high comes in at a $190 price target, and the lowest target sits at $24.

Only 4 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 4 analysts is $1.19 billion; this number has been up and down but is flat now since early June. The highest revenue estimate is $1.30 billion, while the lowest is $1.01 billion.

Onto EBITDA estimates, there are currently only 2 analysts who have third quarter EBITDA estimates. The mean is currently -$15 million, with this number being slightly revised lower since early June. The street high estimate currently sits at $12 million in EBITDA and the lowest is -$42 million.

Analysts estimate that quarterly earnings per share will come in at -$0.52, with this number being flat since early June. Street high is -$0.04 and the lowest estimate is -$0.87 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why This Gold Company Keeps Spinning Out Assets | John-Mark Staude – Riverside Resources

Could This Be Canada’s Next Mid-Tier Gold Producer? | Kevin Bullock – NexGold

Silver at $75 and Why U.S. Silver Ounces Are Getting Hard to Find | Galen McNamara – Silver47

Recommended

Why This Gold Company Keeps Spinning Out Assets | John-Mark Staude – Riverside Resources

Silver at $75 and Why U.S. Silver Ounces Are Getting Hard to Find | Galen McNamara – Silver47

Related News

Medipharm Labs Sees Canaccord Drop Price Target To $0.75

On May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced...

Tuesday, May 18, 2021, 05:32:00 PM

Alamos Gold: Canaccord Lifts Target To $13 On Phase 3+ Expansion Study Results

Alamos Gold Inc. (TSX: AGI) announced their phase 3+ expansion study of Island Gold located...

Saturday, July 2, 2022, 01:20:00 PM

Red Pine Exploration: Haywood Initiates Coverage Withy $1.40 Price Target

Haywood Securities last week initiated coverage on Red Pine Exploration (TSXV: RPX) with a buy...

Tuesday, May 25, 2021, 11:01:00 AM

Harborside Sees Beacon Securities Reiterate $4.75 Price Target

Harborside Inc (CSE: HBOR) this past week announced that they have completed their facility upgrades...

Saturday, July 3, 2021, 12:50:00 PM

Trulieve: Analysts Expect US$221 Million In Q3 Revenues

Trulieve (CSE: TRUL) announced that they will be reporting their third quarter financials before the...

Sunday, November 14, 2021, 04:17:00 PM